The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
Abstract
PURPOSE: This is the first published report on the validation of the Functional Assessment of Cancer Therapy-Breast (FACT-B), a 44-item self-report instrument designed to measure multidimensional quality of life (QL) in patients with breast cancer. The FACT-B consists of the FACT-General (FACT-G) plus the Breast Cancer Subscale (BCS), which complements the general scale with items specific to QL in breast cancer. The FACT-B was developed with an emphasis on patients' values and brevity and is available in nine languages. METHODS AND RESULTS: Two validation samples were used for this report. The first (n = 47) was tested twice over a 2-month period to assess sensitivity to change. Significant sensitivity to change in performance status rating (PSR) was demonstrated for the FACT-B total score, the Physical Well-Being (PWB) subscale, the Functional Well-Being (FWB) subscale, and the BCS. Sensitivity to change in QL as measured by the Functional Living Index-Cancer (FLIC) was documented in the FACT-B total score, PWB, FWB, and Emotional Well-Being (EWB). Additional validity and reliability data were obtained from a larger sample (n = 295). The alpha coefficient (internal consistency) for the FACT-B total score was high (alpha = .90), with subscale alpha coefficients ranging from .63 to .86. Evidence supported test-retest reliability, as well as convergent, divergent, and known groups validity. CONCLUSION: The FACT-B is appropriate for use in oncology clinical trials, as well as in clinical practice. It demonstrates ease of administration, brevity, reliability, validity, and sensitivity to change.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The observed mean improvements presented within this evaluation exceeded this for both groups.”
In the citing paper
“All measures were validated, brief, and non-redundant, supporting parsimony while enabling comprehensive evaluation of intervention impact.”
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Impact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Self-citationShort, homogeneous versions of the Marlow-Crowne Social Desirability Scale
Strahan, R. F., & Gerbasi, K. C. (1972) · Journal of Clinical Psychology · doi:10.1002/1097-4679(197204)28:2 · Cited by 1,657
Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220
Estimates of the worldwide frequency of sixteen major cancers in 1980
Parkin, D. M., Läärä, E., & Muir, C. S. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410205 · Cited by 1,057
Schipper, H., Clinch, J., McMurray, A., & Levitt, M. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.5.472 · Cited by 1,052
Zubrod, C. G., Schneiderman, M. A., Frei, E., Brindley, C. O., Gold, G. L., Shnider, B. I., Oviedo, R., Gorman, J. G., Jones, R., Jonsson, U., et al. (1960) · Journal of Chronic Diseases · doi:10.1016/0021-9681(60)90137-5 · Cited by 1,034
Who should measure quality of life, the doctor or the patient?
Slevin, M., Plant, H., Lynch, D., Drinkwater, J., & Gregory, W. M. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.20 · Cited by 903
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,004
Ye, X., Ren, Z., Vafaei, S., Zhang, J.-M., Song, Y., Wang, Y., & Song, P. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221104092 · Cited by 56
Harder, H., Ballinger, R., Langridge, C., Ring, A. E., & Fallowfield, L. J. (2013) · Psycho-Oncology · doi:10.1002/pon.3338 · Cited by 50
“These scales have good psychometric characteristics and have been used in older cancer populations [22,24].”
MethodLymphedema and quality of life in Chinese women after treatment for breast cancer
Mak, S. S. S., Mo, F. K. F., Suen, J. J. S., Chan, S. L., Ma, W. L., & Yeo, W. (2009) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2009.01.005 · Cited by 50
“QOL was assessed using the Functional Assessment of Cancer Therapy–Breast Cancer subscale (FACT-Bþ 4) questionnaire (Coster et al., 2001).”
MethodResultSelf-citationBulley, C., Gaal, S., Coutts, F., Blyth, C., Jack, W. J. L., Chetty, U., Barber, M. D., & Tan, C.-W. (2013) · BioMed Research International · doi:10.1155/2013/807569 · Cited by 50
Mendoza, T. R., Zhao, F., Cleeland, C. S., Wagner, L. I., Patrick‐Miller, L. J., & Fisch, M. J. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.02.014 · Cited by 50
Fallowfield, L. J., Kilburn, L., Langridge, C., Snowdon, C. F., Bliss, J. M., & Coombes, R. C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.43 · Cited by 50
Patient-Reported Outcomes and Survivorship in Radiation Oncology: Overcoming the Cons
Siddiqui, F., Liu, A. K., Bruner, D. W., & Movsas, B. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.0707 · Cited by 50
Evaluating Minimal Important Differences for the FACT-Melanoma Quality of Life Questionnaire
Askew, R. L., Xing, Y., Palmer, J. L., Cella, D. F., Moyé, L. A., & Cormier, J. N. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00570.x · Cited by 52
Self-citationPsychological effects and mediators of a group multi-component program for breast cancer survivors
Sherman, K. A., Heard, G., & Cavanagh, K. (2010) · Journal of Behavioral Medicine · doi:10.1007/s10865-010-9265-9 · Cited by 52
“…functional and breast cancer-specific components of the FACT-B scale, which is particularly appropriate for use with exercise interventions (Brady et al. 1997), and has proven sensitivity in detecting quality of life-related changes in breast cancer populations (Coster et al. 2001), and in…”
BackgroundResultPatient-reported outcomes in cancer survivorship
Gordon, B.-B. E., & Chen, R. C. (2017) · Acta Oncologica · doi:10.1080/0284186x.2016.1268265 · Cited by 50
“FACT-B [14] Includes FACT-G (see Table 1) plus 10-item breast cancer subscale 44 Higher scores reflect better quality of life English, Chinese, Korean, Malayalam, Spanish”
MethodKrzyzanowska, M. K., Julian, J. A., Gu, C., Powis, M., Li, Q., Enright, K. A., Howell, D., Earle, C. C., Gandhi, S., Rask, S., et al. (2021) · BMJ · doi:10.1136/bmj-2021-066588 · Cited by 49
Tan, J.-Y. B., Molassiotis, A., Suen, L. K. P., Liu, J., Wang, T., & Huang, H. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03543-y · Cited by 49
“QoL The FACT-B is a BC-specific QoL assessment that consists of four general subscales (physical, social/family, emotional, and functional well-being) and one BC-specific subscale [40, 41].”
MethodFertility and parenthood issues in young female cancer patients—a systematic review
Sobota, A., & Özakinci, G. (2014) · Journal of Cancer Survivorship · doi:10.1007/s11764-014-0388-9 · Cited by 50
“Finally, Reh et al. [52] showed that among young cancer patients with various diagnoses referred to a fertility clinic, social domain of QoL as measured by FACT [56] improved over time in those who had undergone FP procedures, with other QoL scores remaining stable over time.”
MethodO’Connell, K. A., & Skevington, S. M. (2007) · Chronic Illness · doi:10.1177/1742395307079195 · Cited by 54
Quality of life in lung cancer: does disclosure of the diagnosis have an impact?
Lheureux, M. (2003) · Lung Cancer · doi:10.1016/j.lungcan.2003.08.018 · Cited by 49
Fong, S. S. M., Ng, S. S. M., Luk, W. S., Chung, J. W. Y., Chung, L. M. Y., Tsang, W. W. N., & Chow, L. P. Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/787169 · Cited by 50
Complementary medicine for fatigue and cortisol variability in breast cancer survivors
Jain, S., Pavlik, D., Distefan, J. M., Bruyere, R. R. L., Acer, J., Garcia, R. R., Coulter, I. D., Ives, J. A., Roesch, S. C., Jonas, W. B., et al. (2011) · Cancer · doi:10.1002/cncr.26345 · Cited by 50
“Time since surgery, mo 27 (2-78) 22 (2-77) 33 (2-108) .”
InfluentialBulley, C., Coutts, F., Blyth, C., Jack, W. J. L., Chetty, U., Barber, M. D., & Tan, C.-W. (2013) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2013.10.006 · Cited by 49
“An additional breast cancer subscale can be added to the FACT G, making it the FACT B, with further possible questions about arm morbidity, making it the FACT B þ 4 (Brady et al., 1997).”
BackgroundResultUnraveling Uses and Effects of an Interactive Health Communication System
Han, J. Y., Hawkins, R. P., Shaw, B. R., Pingree, S., Mctavish, F. M., & Gustafson, D. H. (2009) · Journal of Broadcasting & Electronic Media · doi:10.1080/08838150802643787 · Cited by 49
“These outcomes have been widely tested and demonstrated in terms of reliability, validity, and responsiveness to clinical change (Brady et al., 1997; Gustafson et al., 2001, 2002, 2005).”
BackgroundCerezo, O., Oñate-Ocaña, L. F., Arrieta-Joffe, P., González‐Lara, F., García-Pasquel, M. J., Bargalló‐Rocha, E., & Vilar‐Compte, D. (2012) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2012.01336.x · Cited by 49
“HRQL has been evaluated in several studies with Functional Assessment of Cancer Therapy-General and its subscale, the Functional Assessment of Cancer Therapy-Sub-scale questionnaires (Brady et al. 1997; Lee et al. 2004).”
BackgroundMethodQuality of Life, Mood, and Prognostic Understanding in Patients with Metastatic Breast Cancer
Shin, J. A., El-Jawahri, A. R., Parkes, A. M., Schleicher, S. M., Knight, H. P., & Temel, J. S. (2016) · Journal of Palliative Medicine · doi:10.1089/jpm.2016.0027 · Cited by 49
Quality of life and symptom burden in patients with metastatic breast cancer
Ecclestone, C., Chow, R., Pulenzas, N., Zhang, L., Leahey, A., Hamer, J., DeAngelis, C., Bedard, G., McDonald, R. E., Bhatia, A., et al. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3217-z · Cited by 49
“The FACT-B has been found to have good internal consistency, test-retest reliability and high divergent, convergent and known group validity [11].”
BackgroundBrennan, M. E., Flitcroft, K. L., Warrier, S. K., Snook, K., & Spillane, A. J. (2016) · The Breast · doi:10.1016/j.breast.2016.08.008 · Cited by 49
Papadopoulou, C., Kotronoulas, G., Schneider, A., Miller, M., McBride, J., Polly, Z., Bettles, S., Whitehouse, A., McCann, L., Kearney, N., et al. (2017) · Oncology nursing forum · doi:10.1188/17.onf.127-136 · Cited by 49
Baselga, J. M., Zamagni, C., Gómez, P., Bermejo, B., Nagai, S. E., Melichar, B., Chan, A., Mangel, L., Bergh, J. C. S., Costa, F. P., et al. (2017) · Clinical Breast Cancer · doi:10.1016/j.clbc.2017.05.006 · Cited by 49
Ohsumi, S., Shimozuma, K., Morita, S., Hara, F., Takabatake, D., Takashima, S., Taira, N., Aogi, K., & Takashima, S. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp060 · Cited by 51
“) regularly were asked to complete the patient-administered questionnaires between July 2004 and March 2005 to assess QOL [Functional Assessment of Cancer Therapy scale-Breast: FACT-B (11)] and psychological distress [Hospital Anxiety and Depression Scale: HADS (12)].”
MethodPsychological Aspects of Breast Cancer
Penberthy, J. K., Stewart, A. L., Centeno, C. F., & Penberthy, D. R. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.04.010 · Cited by 48
You, J., & Lü, Q. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0698-4 · Cited by 50
“The reliabilities for all the questionnaires were satisfactory in the current study and were comparable to those in the original English version of questionnaires [42– 44, 46].”
ResultRay, H. A., & Verhoef, M. J. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-205 · Cited by 46
“The baseline quantitative survey included demographic data, disease characteristics and the Functional Assessment of Cancer Therapy-Breast (FACT-B) [55], Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp12) [56], and the Functional Assessment of Cancer Therapy-Fatigue Scale (FACITFa…”
BackgroundMethodInfluentialBatenburg, A., & Das, E. H. H. J. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.2831 · Cited by 48
“Emotional well-being was measured according to 6 items from the Functional Assessment of Chronic Illness Therapy questionnaire (FACIT-B) [45] (Cronbach alpha=.81).”
MethodInfluentialQuality of life after breast cancer surgery: What have we learned and where should we go next?
Pockaj, B. A., Degnim, A. C., Boughey, J. C., Gray, R. J., McLaughlin, S. A., Dueck, A. C., Perez, E. A., Halyard, M. Y., Frost, M. H., Cheville, A. L., et al. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21151 · Cited by 50
Does a Patient-Held Quality-of-Life Diary Benefit Patients With Inoperable Lung Cancer?
Mills, M. E., Murray, L., Johnston, B. T., Cardwell, C. R., & Donnelly, M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5687 · Cited by 48
Aycinena, A. C., Valdovinos, C., Crew, K. D., Tsai, W. Y., Mata, J. M., Sandoval, R., Hershman, D. L., & Greenlee, H. (2016) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-015-0310-1 · Cited by 53
“At baseline and 6-months, quality of life was assessed using the more detailed Functional Assessment of Cancer Therapy-Breast Quality-of-Life Instrument (FACT-B), a 44-item self-report survey for patients with BC [23].”
MethodOngoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer
Başaran, G., Twelves, C. J., Dieras, V. C., Cortés, J., & Awada, A. H. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.12.002 · Cited by 49
Swearingen, A. E. D. V., Siegel, M. B., Deal, A. M., Sambade, M. J., Hoyle, A. P., Hayes, D. N., Jo, H., Little, P., Dees, E. C., Muss, H. B., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4852-5 · Cited by 47
Yanez, B. R., Oswald, L. B., Baik, S. H., Buitrago, D., Iacobelli, F., Perez-Tamayo, A. M., Guitelman, J., Penedo, F. J., & Buscemi, J. (2019) · Psycho-Oncology · doi:10.1002/pon.5281 · Cited by 49
“The 36‐item Functional Assessment of Cancer Therapy–Breast (FACT‐ B) assessed five domains in the context of breast cancer over the past week: breast cancer well‐being (eg, “I am bothered by hair loss” [reverse]), physical well‐being (eg, “I have nausea” [reverse]), social/family well‐being (eg, “I feel close to my fr…”
BackgroundDoctor–Patient Communication about Advance Directives in Metastatic Breast Cancer
Ozanne, E. M., Partridge, A. H., Moy, B., Ellis, K. J., & Sepucha, K. (2009) · Journal of Palliative Medicine · doi:10.1089/jpm.2008.0254 · Cited by 48
Passik, S. D., Kirsh, K. L., Theobald, D., Donaghy, K. B., Holtsclaw, E., Edgerton, S., & Dugan, W. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00493-1 · Cited by 48
Aguirre‐Camacho, A., Pelletier, G., González‐Márquez, A., Blanco‐Donoso, L. M., García‐Borreguero, P., & Moreno‐Jiménez, B. (2017) · Psycho-Oncology · doi:10.1002/pon.4162 · Cited by 47
“For this study, the Spanish adaptation of the FACT-B was used [26].”
BackgroundInfluentialWong, J. S., Uno, H., Tramontano, A. C., Fisher, L., Pellegrini, C., Abel, G. A., Burstein, H. J., Chun, Y. S., King, T. A., Schrag, D., et al. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2024.2652 · Cited by 47
Batenburg, A., & Das, E. H. H. J. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.3517 · Cited by 47
“Specifically, we assessed patients’ intensity of online support group participation, emotional approach coping [25], and 3 measures of well-being that are generally associated with breast cancer diagnosis at 2 points in time: emotional well-being [29], depression [30], and breast cancer-related concerns [31].”
InfluentialBelmonte, R., Garín, O., Badía, M. S., Latiesas, J. S., Marco, E., & Ferrer, M. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2010.11.028 · Cited by 47
Interactivity and presence of three eHealth interventions
Hawkins, R. P., Han, J. Y., Pingree, S., Shaw, B. R., Baker, T. B., & Roberts, L. J. (2010) · Computers in Human Behavior · doi:10.1016/j.chb.2010.03.011 · Cited by 47
“79) assessed the impact of breast cancer and treatment on quality of life; this scale was used and validated extensively in other studies (Brady et al., 1997; Cella, Tulsky, Gray, Sarafian, Linn, Bonomi et al., 1993).”
MethodInfluentialWu, Y.-L. L. C., Fukuoka, M., Mok, T. S. K., Saijo, N., Thongprasert, S., Yang, J. C., Chu, D.-T., Yang, J., & Rukazenkov, Y. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.03.004 · Cited by 47
Therapy choices and quality of life in young breast cancer survivors: a short-term follow-up
Lee, M. C., Bhati, R. S., von Rottenthaler, E. E., Reagan, A., Karver, S. B., Reich, R. R., & Quinn, G. P. (2013) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2013.08.003 · Cited by 47
Quality of Life in 650 Lung Cancer Survivors 6 Months to 4 Years After Diagnosis
Svobodník, A., Yang, P., Novotny, P. J., Bass, E. B., Garces, Y. I., Jett, J. R., Bonner, J. A., & Sloan, J. A. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.8.1024 · Cited by 47
Lee, C. E., Kim, S., Kim, S., Joo, H. M., & Lee, S. H. (2017) · Holistic Nursing Practice · doi:10.1097/hnp.0000000000000220 · Cited by 47
von Moos, R., Body, J., Rider, A., de Courcy, J. J., Bhowmik, D., Gatta, F., Hechmati, G., & Qian, Y. (2017) · Journal of bone oncology · doi:10.1016/j.jbo.2017.11.004 · Cited by 47
“The PSCFs incorporated three instruments to facilitate the collection of PRO data on pain and QoL from patients with BMs and from those with metastases located at sites other than the bone (non-BMs), which included the BPI [24], the 5-dimension 3-level EuroQol questionnaire (EQ-5D), the EuroQol visual analog scale (EQ…”
MethodCheck, D., Chawla, N., Kwan, M. L., Pinheiro, L. C., Roh, J. M., Ergas, I. J., Stewart, A. L., Kolevska, T., Ambrosone, C. B., & Kushi, L. H. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4776-0 · Cited by 47
“The FACT-B is a validated, breast cancerspecific quality of life instrument that has been extensively used to measure quality of life in breast cancer patients and survivors across the care continuum.”
InfluentialDevelopment and Validation of the BREAST-Q Breast-Conserving Therapy Module
Klassen, A. F., Dominici, L. S., Fuzesi, S., Cano, S., Atisha, D. M., Locklear, T., Gregorowitsch, M. L., Tsangaris, E., Morrow, M., King, T. A., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-019-08195-w · Cited by 49
Health-related quality of life assessment after breast reconstruction
Potter, S., Thomson, H. J., Greenwood, R., Hopwood, P., & Winters, Z. (2009) · British journal of surgery · doi:10.1002/bjs.6605 · Cited by 47
Fenlon, D., Corner, J. L., & Haviland, J. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.05.014 · Cited by 47
“3) Marital status No current partner 18 (24) 19 (26) Married/partner 54 (72) 50 (67) Missing data 4 (5) 0 (0) Ethnic origin Caucasian 71 (93) 72 (97) Other (including mixed race) 5 (6) 2 (2) Time since diagnosis Less than 2 years 20 (26) 33 (45) 2e5 years 26 (34) 20 (27) Over 5 years 30 (39) 21 (28) Time since last me…”
An Exploratory Analysis of Fear of Recurrence among African-American Breast Cancer Survivors
Taylor, T. R., Huntley, E. D., Sween, J., Makambi, K. H., Mellman, T. A., Williams, C. D., Carter-Nolan, P. L., & Frederick, W. (2011) · International Journal of Behavioral Medicine · doi:10.1007/s12529-011-9183-4 · Cited by 47
“The FACT-B has been widely used in breast cancer studies and has been found to be reliable, valid, and easy to administer [32].”
MethodYao, L.-Q., Kwok, S. W. H., Tan, J.-Y. B., Wang, T., Liu, X., Bressington, D. T., Chen, S.-L., & Huang, H. (2022) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2022.102202 · Cited by 49
Chen, G., Leary, S. D., Niu, J., Perry, R. E., & Papadaki, A. (2023) · Nutrients · doi:10.3390/nu15092099 · Cited by 47
“The higher the score, the better the QoL [53].”
BackgroundThe Hand-Foot Skin Reaction and Quality of Life Questionnaire: An Assessment Tool for Oncology
Anderson, R. T., Keating, K. N., Doll, H., & CAMACHO, F. T. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0219 · Cited by 47
Mandelblatt, J. S., Luta, G., Kwan, M. L., Makgoeng, S. B., Ergas, I. J., Roh, J. M., Sternfeld, B., Adams-Campbell, L. L., & Kushi, L. H. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1483-5 · Cited by 45
“We used the Functional Assessment of Cancer TherapyBreast Cancer (FACT-B) Version 4 to assess health-related QOL from the baseline interview as our primary outcome measure [9].”
MethodA pilot study on disseminating physical activity promotion among cancer survivors: a brief report
Pinto, B. M., Rabin, C., Abdow, S., & Papandonatos, G. D. (2007) · Psycho-Oncology · doi:10.1002/pon.1268 · Cited by 46
“Significant positive effects were found in participants’ self-reported PA, QOL, fatigue, and vigor at 12 and 24 weeks.”
BackgroundInfluentialLee, C. F., Ng, R. C. H., Luo, N., Wong, N. S., Yap, Y. S., Lo, S. K., Chia, W. K., Yee, A., Krishna, L. K. R., Wong, C., et al. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1512-x · Cited by 46
“The validity and reliability of, and the comparability between the English and Chinese versions of the FACT-B have been previously demonstrated [11, 12, 20].”
BackgroundMethodVrdoljak, E., Marschner, N. W., Zielinski, C. C., Gligorov, J., Cortés, J., Puglisi, F., Aapro, M., Fallowfield, L. J., Fontana, A., Inbar, M., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw316 · Cited by 47
Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review
Huang, M., Haiderali, A., Fox, G. E., Frederickson, A. M., Cortés, J., Fasching, P. A., & O’Shaughnessy, J. (2022) · PharmacoEconomics · doi:10.1007/s40273-021-01121-7 · Cited by 45
“FACT-B FACT-B is an instrument that assesses five domains of HRQoL in BC patients (physical well-being, social well-being, emotional well-being, functional wellbeing, and BC subscale) [68].”
MethodHayes, S. C., Rye, S., Battistutta, D., Yates, P. M., Pyke, C., Bashford, J., & Eakin, E. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.03.015 · Cited by 45
Raz, D. J., Sun, V. C.-Y., Kim, J. Y., Williams, A. C., Koczywas, M., Cristea, M. C., Reckamp, K. L., Hayter, J., Tiep, B. L., & FERRELL, B. R. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.07.031 · Cited by 45
Jones, L. W., Douglas, P. S., Eves, N. D., Marcom, P. K., Kraus, W. E., Herndon, J. E., Inman, B. A., Allen, J. D., & Peppercorn, J. M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-531 · Cited by 46
“QOL will be assessed using the Functional Assessment of Cancer Therapy Breast (FACT-B) scale developed for the assessment of patient symptoms and QOL in breast cancer patients [36].”
Sherman, A. C., Simonton, S., Latif, U., & Bracy, L. (2010) · Journal of Behavioral Medicine · doi:10.1007/s10865-010-9267-7 · Cited by 47
Park, H., & Yoon, H. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1815-6 · Cited by 45
“QOL was measured with the Korean version of Functional Assessment of Cancer Therapy—Breast Cancer Version 4 (FACT-B), and it has been shown to have satisfactory validity [28].”
MethodReview of treatment assessment using DCE-MRI in breast cancer radiation therapy
Wang, C. (2014) · World Journal of Methodology · doi:10.5662/wjm.v4.i2.46 · Cited by 45
Online Support Groups for Women with Metastatic Breast Cancer: A Feasibility Pilot Study
Vilhauer, R. P., McClintock, M. K., & Matthews, A. K. (2010) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2010.504504 · Cited by 45
“…measuring physical well-being, social/family well-being, emotional well-being, functional well-being, and coping with breast cancer-related distress (Brady et al., 1997); the Multidimensional Scale of Perceived Social Support (MSPSS), a 12-item, 7-point, questionnaire with subscales that measure…”
MethodHaviland, J., Hopwood, P., Mills, J., Sydenham, M. A., Bliss, J. M., & Yarnold, J. R. (2016) · Clinical Oncology · doi:10.1016/j.clon.2016.01.011 · Cited by 44
Illness perception and sense of well-being in breast cancer patients
Lee, Y., Baek, J. M., Jeon, Y. W., & Im, E. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s225561 · Cited by 46
“The Functional Assessment of Cancer Therapy for Breast Cancer (FACT-B) was used to assess participants’ sense of well-being on five domains: physical well-being, social/family well-being, emotional well-being, functional well-being, and breast-cancer-specific well-being.(28,29) It is a 36-item questionnaire rated on a…”
MethodZhou, K., Ning, F., Wang, X., Wang, W., Han, D., & Li, X. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01783-1 · Cited by 45
“0 total score (ranging from 0 to 144) is the sum of the ve subscales scores, with a higher score indicating better HRQoL [24].”
BackgroundAnderson, D. J., Seib, C., McCarthy, A. L., Yates, P., Porter-Steele, J., McGuire, A., & Young, L. (2015) · Menopause · doi:10.1097/gme.0000000000000421 · Cited by 45
Zeichner, S. B., Zeichner, R. L., Gogineni, K., Shatil, S., & Ioachimescu, O. (2017) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223417745564 · Cited by 43
“17–21 As they can have a tremendous influence on a patient’s sleep pattern, clinicians should assess for and address the following confounding factors during their initial patient assessment: (1) disease-related (ie, laboratory and radiographic studies and where patients are in their cancer diagnosis/treatment timelin…”
Alava, M. H., Wailoo, A., Pudney, S., Gray, L., & Manca, A. (2020) · Health Technology Assessment · doi:10.3310/hta24340 · Cited by 38
Wang, L., Chen, X., Peng, Y., Zhang, K., Ma, J., Xu, L., Liu, Z., Liu, L., Luo, Y., & Gu, C. (2022) · Journal of Medical Internet Research · doi:10.2196/40059 · Cited by 44
“Missing data (<20%) were handled with the participants’ average response on the remaining scale items, and the missing data in the FACT-B questionnaire were treated by the proportion method per the manual instructions [33].”
MethodScott, J. M., Lee, J., Herndon, J. E., Michalski, M., Lee, C. P., O’Brien, K. A., SASSO, J. P., Yu, A. F., Rowed, K., Bromberg, J., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad085 · Cited by 44
Gupta, S., Zhang, J., & Jérusalem, G. (2014) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2014.949243 · Cited by 44
“Functional assessment of cancer therapy-breast The functional assessment of cancer therapy-breast (FACT-B) was used to measure HRQoL [33,34], consisting of the FACT-General (FACT-G) plus the Breast Cancer Subscale (BCS).”
MethodHendren, S. K., Griggs, J. J., Epstein, R. M., Humiston, S. G., Jean‐Pierre, P., Winters, P., Sanders, M., Loader, S., & Fiscella, K. A. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0537 · Cited by 47
“Furthermore, QOL was measured using wellvalidated instruments with demonstrated sensitivity to change (18, 21).”
Charlson, M. E., Loizzo, J. J., Moadel, A. B., Neale, M., Newman, C., Olivo, E. L., Wolf, E. J., & Peterson, J. C. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-349 · Cited by 44
Shin, S. H., & Park, H. (2017) · Japan Journal of Nursing Science · doi:10.1111/jjns.12161 · Cited by 44
Baik, S. H., Oswald, L. B., Buitrago, D., Buscemi, J., Iacobelli, F., Perez-Tamayo, A. M., Guitelman, J., Diaz, A., Penedo, F. J., & Yanez, B. R. (2020) · International Journal of Behavioral Medicine · doi:10.1007/s12529-020-09890-9 · Cited by 47
“55) [44] as well as other samples of Latina BCS (M = 105; SD = 19.”
BackgroundMethodCostet, N., Lapierre, V., Benhamou, E., & Galès, C. L. (2005) · Quality of Life Research · doi:10.1007/s11136-004-5531-z · Cited by 44
“Comparison of results from this study with findings from other studies [6, 7, 20, 21] is not strictly valid since previous studies involved prior versions of the questionnaire.”
ResultAuchter, R. M., Scholtens, D. M., Adak, S., Wagner, H., Cella, D. F., & Mehta, M. P. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01604-2 · Cited by 44
Self-citationPark, J.-H., Jung, Y. S., Jung, Y.-M., & Bae, S. H. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-018-4546-x · Cited by 43
Clarijs, M. E., Thurell, J., Kühn, F., Groot, C. A. U., Hedayati, E., Karsten, M. M., Jager, A., & Koppert, L. B. (2021) · Cancers · doi:10.3390/cancers13102308 · Cited by 45
“ESAS, FACT-B Meisel, J.L. et al., 2012 [40] To evaluate psychological adjustment of women living long-term with metastatic disease Cross-sectional study 28 eligible US women, of which 18 completed the questionnaires.”
InfluentialLin, Y., Wu, C., He, C., Yan, J., Chen, Y., Gao, L., Liu, R., & Cao, B. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07494-5 · Cited by 47
Quality of life among a population-based cohort of older patients with breast cancer
Neuner, J. M., Zokoe, N., McGinley, E. L., Pezzin, L. E., Yen, T. W. F., Schapira, M. M., & Nattinger, A. B. (2014) · The Breast · doi:10.1016/j.breast.2014.06.002 · Cited by 43
“The FACT-B BCS includes nine items regarding bother or worry about cancer and symptoms over the previous seven days, and has had extensive reliability and validity testing [43].”
MethodExpressive Writing in Women With Advanced Breast Cancer
Laccetti, M. (2007) · Oncology nursing forum · doi:10.1188/07.onf.1019-1024 · Cited by 43
“Despite that fact that item analysis was used extensively in developing the FACT-B to reduce item content redundancy (Brady et al., 1997), some overlap may still exist.”
Marino, J. L., Saunders, C. M., Emery, L. I., Green, H., Doherty, D. A., & Hickey, M. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000664 · Cited by 43
Trajectories of quality of life following breast cancer diagnosis
Goyal, N. G., Levine, B. J., Zee, K. J. V., Naftalis, E. Z., & Avis, N. E. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4677-2 · Cited by 44
“The Functional Assessment of Cancer Therapy-Breast (FACT-B [13]), a breast cancer-specific measure, is considered to be more sensitive to disease-related changes * Nancy E. Avis navis@wakehealth.edu 1 Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, N…”
BackgroundMethodInfluentialGrossberg, A. J., Lei, X. J., Xu, T., Shaitelman, S. F., Hoffman, K. E., Bloom, E. S., Stauder, M. C., Tereffe, W., Schlembach, P. J., Woodward, W. A., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2583 · Cited by 43
“Breast Cancer (FACT-B) module trial outcome index.(30) Each”
BackgroundGarcia, S. F., Rosenbloom, S. K., Beaumont, J. L., Merkel, D. E., Roenn, J. H. V., Rao, D., & Cella, D. F. (2011) · Value in Health · doi:10.1016/j.jval.2011.08.1739 · Cited by 44
Self-citationDaley, A. (2004) · Health Education Research · doi:10.1093/her/cyg094 · Cited by 43
“This change represents a shift from being fully ambulatory with symptoms to being fully ambulatory without symptoms (Brady et al., 1997).”
BackgroundLyons, K. D., Hull, J. G., Kaufman, P. A., Li, Z., Seville, J. L., Ahles, T. A., Kornblith, A. B., & Hegel, M. T. (2015) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2014.1002659 · Cited by 42
“The Functional Assessment of Cancer Therapy-Breast Cancer + Arm Morbidity (FACT-B+4) is a 41-item self-report measure of health-related quality of life specifically designed for breast cancer patients (Brady et al., 1997; Coster, Poole, & Fallowfield, 2001).”
BackgroundWang, J., Lu, K., Song, Y., Xie, L., Zhao, S., Wang, Y., Sun, W., Liu, L., Zhao, H., Tang, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068798 · Cited by 41
“Repaired the scales (WOMAC, M-SACRAH, BPI-SF and FACT-G) and told the patients how to write: WS HZ DT WM.”
MethodInfluentialPaek, M.-S., Ip, E. H., Levine, B. J., & Avis, N. E. (2016) · Annals of Behavioral Medicine · doi:10.1007/s12160-016-9803-y · Cited by 42
“Mean FACT-B domain scores by survey time points Ann Behav Med.”
MethodInfluentialReturn to work after breast cancer diagnosis: An observational prospective study in Brazil
Landeiro, L. C. G., Gagliato, D. D. M., Fêde, Â., Fraile, N. M. P., López, R. V. M., da Fonseca, L. G., Petry, V., Testa, L., Hoff, P. M., & Mano, M. S. (2018) · Cancer · doi:10.1002/cncr.31735 · Cited by 44
“QOL was assessed at 6, 12, and 24 months after diagnosis using the FACT-B questionnaire.(16) Clinical variables included cancer stage, immunohistochemistry, cancer-directed treatment (chemotherapy, radiotherapy, endocrine therapy, and antihuman epidermal growth factor receptor 2 [anti-HER2] therapy), comorbidity, and…”
MethodZhou, K., Wang, W., An, J., Li, M., Li, J., & Li, X. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07305-y · Cited by 42
Kupeli, N., Chatzitheodorou, G., Troop, N., McInnerney, D., Stone, P. C., & Candy, B. (2019) · BMC Palliative Care · doi:10.1186/s12904-019-0449-y · Cited by 52
Value Lies in the Eye of the Patients: The Why, What, and How of Patient-reported Outcomes Measures
Ciani, O., & Federici, C. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.11.016 · Cited by 42
Metadata
- Authors
- Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., Cobleigh, M., & Shiomoto, G.
- Affiliations
- Rush University Medical Center (US)
- Rush University (US)
- Venue
- Journal of Clinical Oncology
- Published
- 1997-03
- Volume
- 15
- Issue
- 3
- Pages
- 974-986
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1857624176
- Cited by
- 1,752
- References
- 39
- Citations by year
- 2026: 47 · 2025: 76 · 2024: 77 · 2023: 71 · 2022: 97 · 2021: 88 · 2020: 78 · 2019: 87 · 2018: 83 · 2017: 85 · 2016: 83 · 2015: 73 · 2014: 83 · 2013: 70 · 2012: 86
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r29ca051926-01a1)
- National Cancer Institute (R29CA51926)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Nursing › Research and Theory › Health Education and Validation
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- FACT-B, breast cancer, quality of life, FACT-G, instrument validation, sensitivity to change, test-retest reliability, internal consistency, known-groups validity, convergent validity, discriminant validity, physical well-being, functional well-being, emotional well-being, Functional Living Index-Cancer, self-report questionnaire
- MeSH terms
- Adult, Aged, Aged, 80 and over, Breast Neoplasms, Female, Humans, Middle Aged, Quality of Life, Self Concept, Sensitivity and Specificity, Severity of Illness Index, Translations, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review